key: cord-0850530-99p2xn4d authors: Trinidad, Carlo Nemesio B. title: Perpetual Lockdown: The state of COVID-19 and kidney disease in the Philippines date: 2021-08-03 journal: Kidney Int Rep DOI: 10.1016/j.ekir.2021.07.018 sha: 193ac20b744402e70064bbbe393f1a5cdec00fb4 doc_id: 850530 cord_uid: 99p2xn4d nan Contact tracing remains a weak link in the country's response, with falling contact tracing ratios attributed to lack of uniform data collection, lack of trained contact tracers and poor coordination with the local government units 2 . The Philippines has lagged in the testing arena as well, reaching a maximum of 62,466 tests per day (Supplementary Figure S1 ). The persistently high positivity rates (ranging from 10.3 to 23.8% starting mid-March 2021) 3 point to the fact that the Philippines was not performing enough tests daily to detect new cases. Local transmission amongst dialysis patients within centers were not uncommon as contact tracing procedures were not exhaustive and RT-PCR tests were conducted sparingly because few patients could afford them. Even when RT-PCR was performed, the scarcity of capable testing centers and slow turnaround time of test results limited the ability of the dialysis centers to immediately separate SARS-Cov-2 positive dialysis patients from their non-infected peers. The sudden upswing in COVID-19 cases during the start of March 2021 saw hospitals experience a spike in admissions and occupancy. In its largest island Luzon, most hospitals designated to manage severe COVID-19 cases are centered in the National Capital Region (NCR). When the country tallied its largest daily new cases in April 2021), the Department of Health reported that 85.28% of the total ICU beds for COVID-19 in NCR were occupied. Furthermore, thirty-two of its hospitals reached 100% bed occupancy 4 . In the Philippine General Hospital, the country's largest COVID-19 referral center, bed capacity has hovered around 90% since the beginning of May. Spillover of patients requiring hospital care to nearby provinces was imminent. People began seeking hospitals with vacant beds in desperation, traveling as far north as the Ilocos Region and as far south as the Bicol Region (both more than 300 kilometers from Manila). Government outpatient nephrology clinics ceased operations during the start of the pandemic as most of its resources were diverted to the containment and treatment of COVID-19 patients. Philippine General Hospital, the country's largest tertiary and training hospital, was converted to a COVID-19 referral center on March 30, 2020 5 . This led to the closure of the outpatient department catering large numbers of CKD charity patients. Outpatient hemodialysis patients were transferred to other centers in preparation for the care of COVID-19 dialysis patients. Those who were seen by private outpatient clinics were likewise unable to make face to face consultations with their attending nephrologists due to the movement restrictions imposed by the nationwide lockdown. During the early days of the pandemic, hemodialysis centers were not prepared to handle the COVID-19 surge. While hospital-based dialysis centers had provisions for isolation areas and personal protective equipment, free-standing centers were ill-equipped to handle COVID positive or suspect patients. In a survey done among 27 hemodialysis centers (most of which were free standing facilities) serving almost 1700 patients, only 8 of them were equipped to handle positive patients ( Figure 1 ). These centers only had the capacity to cater to 27 COVID-19 patients in a day. Symptomatic patients were advised to transfer to other centers. Dedicated COVID-19 dialysis centers were designated through the concerted efforts of the Philippine Society of Nephrology and local government units but were soon overwhelmed with the increasing number of patients. National Kidney and Transplant Institute, which contains the country's largest government hemodialysis facility, had already sought assistance in accommodating the growing COVID-19 dialysis patients 6 . Some centers were forced to do dialysis with cohort isolationthe practice of placing suspect or positive patients in a different shift. Even then, some centers developed local COVID-19 transmission among their patients and staff, resulting in their temporary closure. This further exacerbated the shortage of available dialysis centers that could cater to COVID-19 positive patients. Symptomatic patients had to pay for their RT-PCR testing as well as shoulder additional expenses during cohort dialysis (to cover the fees for PPE and hazard pay of staff) amounting to tens and thousands of pesos. Patients who did not have the financial capability to pay the extra fees had to queue to government centers already filled to the brim with patients. In the survey mentioned above, 267 out of 1675 patients (16%) developed COVID-19. 91 (34%) of them would succumb to the disease (Figure 1 ). In a study in Philippine General Hospital by Tomacruz et al., mortality among admitted ESKD patients with COVID-19 was high at 25% 7 . Due to difficulties brought about by the pandemic like loss of income, lack of dedicated COVID-19 dialysis centers and shortage of dialysis center manpower, some patients were unable to resume their regular treatment sessions and end up suffering pulmonary congestion and other complications leading to hospitalization or death. While actual data is lacking, there is consensus among the nephrologists in the country that there is a significant proportion of patients whose fatalities can be attributed to complications of missed dialysis treatments. The pandemic brought about a silver lining for chronic dialysis patients, in the form of the Bayanihan to Recover as One Act. Under this act, the number of dialysis treatments subsidized by Philhealth annually was increased from 90 to 144 sessions until December 31, 2020 8 . This somewhat alleviated the out-of-pocket expenses of hemodialysis patients and enabled them to fully comply with their thrice-weekly dialysis sessions. Majority of kidney transplant surgeries in the Philippines are based in the island of Luzon. Even before the pandemic, the number of kidney transplant procedures was already low. National Kidney and Transplant institute only had 561 kidney transplants last 2018 and 535 transplants last 2019. From January to March 2020, the transplants decreased to only 107. As it underwent lockdown on March 2020, all transplant centers ceased performing procedures to minimize the exposure of transplant patients to COVID-19. Deceased donor procurement activities were also suspended 9 . While some of the institutions have resumed performing a limited number of procedures this year, kidney transplantation in the country is effectively stifled for the foreseeable future. The Philippines was the last Southeast Asian country to receive its vaccines on February 28, 2021. With its initial 600,000 donated CoronaVac shots, the Philippines started its rollout on March 1. It has administered over 5 million doses (equivalent to 2% of the total population) running at an average of about 140,000 vaccinations per day. Fully vaccinated individuals have reached 3.4 million or only 4.81% of the total population (Supplementary Figure S2 ). This is a far-cry from the government's projected 70 million target to achieve herd immunity by the end of 2021. As of June 14, 2021, the country had vaccinated with the first dose over 1.7 million people belonging to the A3 priority group, which includes patients with CKD, on hemodialysis and those who underwent kidney transplant. Out of 1675 hemodialysis patients in the survey, 430 (25.7%) have received at least one dose while 265 (15.8%) are fully vaccinated (Figure 1 ). Vaccine hesitancy, slow vaccine rollout and rampant misinformation all contribute to the low vaccination rate in the country. Six in 10 Filipinos did not want to get the vaccine citing safety concerns as the leading reason for vaccine hesitancy S1 . Informal interviews of the author among dialysis patients reveal their fear of being vaccinated due to their immunocompromised state. Delays in releasing vaccines from storage facilities, supply issues, transportation issues, and other challenges all serve as bottlenecks that hamper vaccine deployment. The inefficiency trickles down to the municipal level, where lack of coordination, proper communication and scheduling have caused confusion among those waiting to be vaccinated. Misinformation regarding the dangers of COVID-19 vaccines and fraudulent claims of deaths attributed to vaccines continue to make rounds in Facebook. The social media platform has become a breeding ground for conspiracy theories and snake oils that fuel doubts about the vaccines. The end of the COVID-19 pandemic is still far from sight in the country. With its healthcare system already stretched thin just from battling COVID-19, it cannot deal effectively with other diseases like chronic kidney disease at the same time. Dealing with COVID-19 as quick as possible is key not only to the resumption to normalcy but to increasing the survival and quality of life of Filipinos with kidney disease. There should be a concerted effort by the government to improve its pandemic response and flatten the curve as fast as possible. The race to end COVID-19 in the country may well become a race to protect CKD patients as well. The author declares no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Situation in WHO -Western Pacific Region Magalong: Contact tracing is worsening in PH Coronavirus Pandemic (COVID-19 COVID-19 beds in 22 NCR hospitals 100% filled, 42 in critical level -DOH. INQUIRER.Net UP-PGH begins operating as COVID-19 referral center NKTI seeks relief from COVID-19 overcapacity Clinical Characteristics and Short-Term Outcomes of Chronic Dialysis Patients Admitted for COVID-19 in Metro Manila Transplantation in Asia during the coronavirus disease-19 (COVID-19) pandemic: briefs from member countries of the Asian Society of Transplantation Figure 1. Survey of Hemodialysis Centers in the Philippines